Maysa Abu Khalaf, MD

Dr. Abu-Khalaf's clinical expertise encompasses the management of early-stage and metastatic breast cancer, including inflammatory breast cancer and breast cancer in men. She is actively involved in clinical trials, focusing on novel therapeutic approaches to improve patient outcomes. Dr. Abu Khalaf's research interests include investigating the molecular mechanisms of resistance to endocrine therapy and CDK4/6 inhibitors in metastatic breast cancer. She has also contributed to studies on the efficacy of PARP inhibitors for BRCA1/2-mutated metastatic breast cancer and the impact of social determinants of health on cancer care

Medical School

The University of Jordan Faculty of Medicine, Amman, Jordan  - 1995

Residency

Internal Medicine, Norwalk Hospital-Yale University, Norwalk, CT

Fellowship

Medical Oncology, Yale University School of Medicine, Yale-New Haven Hospital, New Haven, CT